Skip to content

Blog

Category: ATMP

Update on CAR T-Cell Therapies for the Treatment of Cancer

  • September 16, 2021
  • ATMP

Chimeric Antigen Receptor (CAR) therapies are a type of cell therapy that consists of modifying immune cells to attack various forms of cancerous cells. While…

Read More

The Benefits of Outsourcing R&D Processes to CROs

  • February 2, 2021
  • ATMP

As a leading contract research organization (CRO), BioAgilytix helps companies around the world with research and development, leveraging expertise in cell-based assays, immunogenicity, biomarkers and…

Read More